The Role of Timely Insulin Initiation

Timely initiation of insulin therapy remains one of the most powerful, yet frequently postponed, interventions for optimising glycaemic control in people living with diabetes. Clinical inertia, patient apprehension, and systemic constraints often delay therapy until preventable complications emerge. In this highly interactive, faculty‑led webinar, internationally recognised experts will distil the clinical evidence, regional data, and practical strategies that demonstrate how early insulin initiation can transform outcomes. Participants will engage with real‑world case studies from the EWA context, receive practical communication frameworks, and leave equipped to champion patient‑centred, guideline‑concordant care.

WHY YOU SHOULD ATTEND

i. Protect your patients: Discover how acting sooner rather than later can arrest the progression of micro‑ and macro‑vascular complications.

ii. Earn accredited CPD points: Attendance is accredited by the Medical and Dental Council (MDC) and counts toward your annual professional requirements.

iii. Strengthen your clinical decision‑making: Apply evidence‑based algorithms and regional data to confidently start insulin when oral therapy is no longer enough.

iv. Enhance patient acceptance: Master persuasive yet empathetic communication techniques that address common fears and improve adherence.

v. Network with peers: Exchange insights with colleagues facing similar challenges across West Africa.

EVENT HIGHLIGHTS

1. Expert Keynote – Current evidence on early insulin initiation and its impact on long‑term outcomes.

2. Regional Epidemiology Snapshot – Latest data on diabetes prevalence and burden in West Africa.

3. Interactive Case‑Based Workshop – Step‑by‑step insulin initiation with anonymised participant polling and feedback.

4. Live Q & A – Direct access to the faculty for clarifying clinical dilemmas.

5. Downloadable Toolkit – Quick‑reference algorithms, patient conversation guides, and dose‑titration charts.

6. Accreditation & Certificate – Automatic issuance of MDC‑recognised CPD credits upon full attendance.

SUMMARY OF TOPICS

1. Diabetes Epidemiology and Burden of Complications

2. Pathophysiology of Type 2 Diabetes Mellitus

3. Screening Strategies and Glycaemic Targets

4. Importance of Tight Glycaemic Control in T2DM

5. Clinical Guidance for Insulin Initiation – Algorithms, dose selection, titration, monitoring

6. Patient‑Centred Approaches – Overcoming barriers, counselling, shared decision‑making

7. Regional Insights & Case Studies – EWA‑specific considerations

8. Case Study Walk‑Through & Live Discussion

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for The Role of Timely Insulin Initiation, you consent to participate in this training hosted by Continuous Education Services (CES) on behalf of Novo Nordisk. Your registration provides CES with the information required to facilitate the event and to issue CPD accreditation through the Medical and Dental Council (MDC). CES is committed to safeguarding your personal information: no personal data will be shared with Novo Nordisk. Data will be disclosed only to relevant regulatory bodies (e.g., MDC) strictly for the purpose of awarding CPD points. Participants may opt out of the meeting at any time without further obligation. Your privacy will be respected, and all participation records will be handled with the highest level of confidentiality.

SUPPORTED BY

This will be a LIVE virtual event. Thursday the 14th of August 2025. This event will be streamed live on this page.

Date: Thursday the 14th of August 2025

Time: 1500 - 1600 GMT (3:00-4:00 pm Local Time) 

Target Audience: Medical Doctors

The agenda is available to download in the downloads section.